Key facts
- This page summarizes John D. Harkey Jr.'s Form 4 filing for ZUORA INC.
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Feb 2025, 16:05.
John D. Harkey Jr. - 14 Feb 2025 Form 4 Insider Report for ZUORA INC
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 14 Feb 2025
- Net transaction value
- -$3,445,670
- SEC form
- 4
- Accepted by SEC
- 14 Feb 2025, 16:05:52 UTC
- Prior SEC filing
- 02 Dec 2024
- Next SEC filing
- 03 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Diana Lorenz as attorney-in-fact for John D. Harkey Jr.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John D. Harkey Jr. filed Form 4 for ZUORA INC on 14 Feb 2025.
Change
- Previous filing in this sequence was filed on 02 Dec 2024.
- Current net transaction value: -$3,445,670.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZUO
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- $435,670
- Shares
- -43,567
- Change %
- -100%
- Price
- $10.00
- Shares after
- 0
- Date
- 14 Feb 2025
- Ownership
- Direct
- Footnotes
- F1, F2
ZUO
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- $2,010,000
- Shares
- -201,000
- Change %
- -100%
- Price
- $10.00
- Shares after
- 0
- Date
- 14 Feb 2025
- Ownership
- By JDH Life Sciences, Inc.
- Footnotes
- F1, F3
ZUO
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- $1,000,000
- Shares
- -100,000
- Change %
- -100%
- Price
- $10.00
- Shares after
- 0
- Date
- 14 Feb 2025
- Ownership
- By Abraxus Trust
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
John D. Harkey Jr. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 4 footnotes
Footnote F1
On February 14, 2025 (the "Effective Time"), pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of October 17, 2024, by and among Zodiac Purchase, L.L.C. ("Parent"), Zodiac Acquisition Sub, Inc. ("Merger Sub") and Zuora (the "Company"), Merger Sub merged with and into the Company with the Company surviving the merger as a wholly owned subsidiary of Parent. At the Effective Time, each of the Reporting Person's shares of Class A Common Stock (the "Common Stock"), issued and outstanding immediately prior to the Effective Time were automatically canceled and converted into the right to receive $10.00 per share in cash without interest thereon, and less any applicable tax withholdings (the "Merger Consideration").
Footnote F2
Includes unvested restricted stock units ("RSUs") of the Company. Pursuant to the Merger Agreement, at the Effective Time, each of the Reporting Person's RSUs, whether or not vested, outstanding immediately prior to the Effective Time were automatically canceled and converted into the right to receive cash equal to the product of the number of shares of Common Stock subject to the RSU multiplied by the Merger Consideration (the "Converted RSU Award"). The Converted RSU Award will vest and become payable subject to and in accordance with the same vesting schedule and other terms and conditions applicable to the corresponding RSU immediately prior to the Effective Time, including any acceleration of vesting provisions.
Footnote F3
Reporting Person is the president and sole beneficial owner of JDH Life Sciences, Inc., and may be deemed to share voting and dispositive power with regard to the shares held by JDH Life Sciences, Inc., with Scalar Gauge Management, LLC (the Account Manager).
Footnote F4
Reporting Person is the trustee and sole beneficiary of the Abraxus Trust and may be deemed to have sole voting and dispositive power with regard to the shares held by the Abraxus Trust.